Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma

Neuro-Oncology

Volumn 6, Issue 3, 2004, Pages 200-207

  Rood, Brian R ^a,c   Zhang, Huizhen ^a   Cogen, Philip H ^b  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; CANCER CELL; CELL HETEROGENEITY; CELL NUCLEUS; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DNA REPAIR; ENZYME DEFICIENCY; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CEREBELLAR NEOPLASMS; CHILD; DNA METHYLATION; DNA REPAIR; EXTRACELLULAR FLUID; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDULLOBLASTOMA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RNA, MESSENGER;

EID: 4344659610     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000565     Document Type: Article

References (29)

1. Bae, S.I., Lee, H.S., Kim, S.H., and Kim, W.H. (2002) Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hyper-methylation in gastric cancers. Br. J. Cancer 86, 1888-1892.
2. Belanich, M., Pastor, M,, Randall, T, Guerra, D., Kibitel, J., Alas, L., Li, B., Citron, M., Wasserman, R, White, A., Eyre, H., Jaeckle, K., Schulman, S., Rector, D., Prados, M., Coons, S., Shapiro, W., and Yarosh, D. (1996) Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res. 56, 783-788.
3. Bobola, M.S., Berger, M.S., Ellenbogen, R.G., Roberts, T.S., Geyer, J.R., and Silber, J.R. (2001) O6-Methylguanine-DNA methyltransferase in pediatric primary brain tumors: Relation to patient and tumor characteristics. Clin. Cancer Res. 7, 613-619.
4. Costello, J.F., Futscher, B.W., Tano, K., Graunke, D.M., and Pieper, R.O. (1994) Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J. Biol. Chem. 269, 17228-17237.
5. Danam, R.P., Qian, X.C., Howell, S.R., and Brent, TP. (1999) Methylation of selected CpGs in the human O6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing. Mol. Carcinog. 24, 85-89.
6. Deng, C.J., Xie, D.W., Capasso, H., Zhao, Y.J., Wang, L.D., and Hong, J.Y. (1999) Genetic polymorphism of human O6-alkylguanine-DNA alkyltransferase: Identification of a missense variation in the active site region. Pharmacogenetics 9, 81-87.
7. Edara, S., Kanugula, S., and Pegg, A.E. (1999) Expression of the inactive C145A mutant human O6-alkylguanine-DNA alkyltransferase in E. coli increases cell killing and mutations by N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 20, 103-108.
8. Esteller, M., Hamilton, S.R., Burger, P.C., Baylin, S.B., and Herman, J.G. (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res, 59, 793-797.
9. Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S.N., Hidalgo, O.F., Vanaclocha, V., Baylin, S.B., and Herman, J.G. (2000a) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 343, 1350-1354.
10. Esteller, M., Toyota, M., Sanchez-Cespedes, M., Capella, G., Peinado, M.A., Watkins, D.N., Issa, J.P., Sidransky, D., Baylin, S,B., and Herman, J.G. (2000b) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 60, 2368-2371.
11. Fornace, A.J., Jr., Papathanasiou, M.A., Hollander, M.C., and Yarosh, D.B. (1990) Expression of the O6-methylguanine-DNA methyltransferase gene MGMT in MER+ and MER- human tumor cells. Cancer Res. 50, 7908-7911.
12. Frommer, M., McDonald, L.E., Millar, D.S., Collis, C.M., Watt, F, Grigg, G.W., Molloy, P.L., and Paul, C.L, (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89, 1827-1831.
13. He, X.M., Ostrowski, L.E., von Wronski, M.A., Friedman, H.S., Wikstrand, C.J., Bigner, S.H., Rasheed, A., Batra, S.K., Mitra, S., Brent, T.P., and Bigner, D.D. (1992) Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines. Cancer Res. 52, 1144-1148.
14. Herfarth, K.K., Brent, T.P., Danam, R.P., Remack, J.S., Kodner, I.J., Wells, S.A., Jr., and Goodfellow, P.J. (1999) A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol. Carcinog. 24, 90-98.
15. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D., and Baylin, S.B. (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl. Acad. Sci. USA 93, 9821-9826.
16. Hongeng, S., Brent, T.P., Sanford, R.A., Li, H., Kun, L.E., and Heideman, R.L. (1997) O6-Methylguanine-DNA methyltransferase protein levels in pediatric brain tumors. Clin. Cancer Res. 3, 2459-2463.
17. Jaeckle, K.A., Eyre, H.J., Townsend, J.J., Schulman, S., Knudson, H.M., Belanich, M., Yarosh, D.B., Bearman, S.I., Giroux, D.J., and Schold, S.C. (1998) Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bischloroethylnitrosourea: A Southwest Oncology Group study. J. Clin. Oncol. 16, 3310-3315.
18. Kanugula, S., Goodtzova, K., Edara, S., and Pegg, A.E. (1995) Alteration of arginine-128 to alanine abolishes the ability of human O6-alkylguanine-DNA alkyltransferase to repair methylated DNA but has no effect on its reaction with O6-benzylguanine. Biochemistry 34, 7113-7119.
19. NIH. National Institutes of Health (2003) GenBank. National Center for Biotechnology Information (available at http://www.ncbi.nlm.nih.gov/Genbank).
20. Packer, R.J., Meadows, A.T, Rorke, L.B., Goldwein, J.L., and D'Angio, G. (1987) Long-term sequelae of cancer treatment on the central nervous system in childhood. Med. Pediatr Oncol. 15, 241-253.
21. Packer, R.J., Sutton, L.N., Atkins, T.E., Radcliffe, J., Bunin, G.R., D'Angio, G., Siegel, K.R., and Schut, L. (1989) A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J. Neurosurg. 70, 707-713.
22. Packer, R.J., Sutton, L.N., Elterman, R., Lange, B., Goldwein, J., Nicholson, H.S., Mulne, L., Boyett, J., D'Angio, G., Wechsler-Jentzsch, K., Reaman, G., Cohen, B.H., Bruce, D.A., Rorke, L.B., Molloy, P., Ryan, J., Lafond, D., Evans, A.E., and Schut, L. (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J. Neurosurg. 81, 690-698.
23. Pieper, R.O., Lester, K.A., and Fanton, C.P. (1999) Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts. Nucleic Acids Res. 27, 3229-3235.
24. Qian, X.C., and Brent, T.P. (1997) Methylation hot spots in the 5′ flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Cancer Res. 57, 3672-3677.
25. Silber, J.R., Mueller, B.A., Ewers, T.G., and Berger, M.S. (1993) Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res. 53, 3416-3420.
26. Silber, J.R., Bobola, M.S., Ghatan, S., Blank, A., Kolstoe, D.D., and Berger, M.S. (1998) O6-methylguanine-DNA methyltransferase activity in adult gliomas: Relation to patient and tumor characteristics. Cancer Res. 58, 1068-1073.
27. Srivenugopal, K.S., Shou, J., Mullapudi, S.R., Lang, F.F., Jr., Rao, J.S., and Ali-Osman, F. (2001) Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. Clin. Cancer Res. 7, 1398-1409.
28. Watts, G.S., Pieper, R.O., Costello, J.F., Peng, Y.M., Dalton, W.S., and Futscher, B.W. (1997) Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol. Cell Biol. 17, 5612-5619.
29. Yuan, Q., Matsumoto, K., Nakabeppu, Y, and lwaki, T (2003) A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas. Neuropathology 23, 203-209.